Prostate Specific Membrane Antigen Positron Emission Tomography May Improve the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging in Localized Prostate Cancer-Reference-Cited by-同舟云学术

Prostate Specific Membrane Antigen Positron Emission Tomography May Improve the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging in Localized Prostate Cancer

Published:2016-10 Issue:4 Volume:196 Page:1261-1267
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Rhee H.¹²,Thomas P.³,Shepherd B.⁴,Gustafson S.⁵,Vela I.¹²,Russell P.J.²,Nelson C.²,Chung E.¹,Wood G.⁶,Malone G.¹⁶,Wood S.¹⁶,Heathcote P.¹⁶²

Affiliation:

1. Department of Urology, Princess Alexandra Hospital, Queensland, Australia

2. Australian Prostate Cancer Research Centre–Queensland, Institute of Health and Biomedical Innovation, Faculty of Health, Queensland University of Technology, Princess Alexandra Hospital, Translational Research Institute, Queensland, Australia

3. Department of Nuclear Medicine, Royal Brisbane and Women’s Hospital, Queensland, Australia

4. Pathology Queensland, Princess Alexandra Hospital, Queensland, Australia

5. Department of Radiology, Princess Alexandra Hospital, Queensland, Australia

6. Department of Urology, Greenslopes Private Hospital, Queensland, Australia

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference25 articles.

1. Quality-of-life effects of prostate-specific antigen screening;Heijnsdijk;N Engl J Med,2012

2. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies;Pokorny;Eur Urol,2014

3. Is it time to consider a role for MRI before prostate biopsy?;Ahmed;Nat Rev Clin Oncol,2009

4. Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology;Le;Eur Urol,2015

5. National Institute for Health and Care Excellence: Prostate cancer: diagnosis and management. Clinical guideline 175 (Update of clinical guideline 58). Available at http://www.nice.org.uk/guidance/cg175/evidence/cg175-prostate-cancer-full-guideline3.

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analytical performance validation of aPROMISE platform for prostate tumor burden, index and dominant tumor assessment with 18F-DCFPyL PET/CT. A pilot study;Scientific Reports;2024-02-06

2. Multimodal radiomics based on 18F-Prostate-specific membrane antigen-1007 PET/CT and multiparametric MRI for prostate cancer extracapsular extension prediction;British Journal of Radiology;2023-12-13

3. Head-to-Head Comparison of 18F-PSMA-1007 Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging with Whole-mount Histopathology as Reference in Localisation and Staging of Primary Prostate Cancer;European Urology Oncology;2023-12

4. Correlation between Prostate Cancer Positive Cores and <sup>68</sup>Ga-PSMA Distribution in Prostate Gland;Urologia Internationalis;2023-11-28

5. Head-to-head comparison of prostate-specific membrane antigen PET and multiparametric MRI in the diagnosis of pretreatment patients with prostate cancer: a meta-analysis;European Radiology;2023-11-20